US Stock MarketDetailed Quotes
SIOX Sio Gene Therapies
- 0.478000
- 0.0000000.00%
15min DelayTrading Feb 7 16:00 ET
35.36MMarket Cap-1225P/E (TTM)
0.000000High0.000000Low0Volume0.000000Open0.478000Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)73.98MShares0.50000052wk High0.78P/B22.98MFloat Cap0.25000052wk Low--Dividend TTM48.07MShs Float19.600000Historical High--Div YieldTTM0.00%Amplitude0.230300Historical Low--Avg Price1Lot Size
About Sio Gene Therapies Company
Sio Gene Therapies Inc is a clinical-stage company that is focused on gene therapy for neurodegenerative diseases. The company is developing its pipeline for the treatment of debilitating diseases, including Parkinson's disease, GM1 gangliosidosis, and GM2 gangliosidosis.
Company Profile
SymbolSIOX
Company NameSio Gene Therapies
Issue Price15.00
CEOMr. David W. Nassif, J.D.
MarketPink Market
Employees12
Securities TypeOrdinary Shares
Fiscal Year Ends03-31
Websitehttps://www.siogtx.com
Company Executives
- Name
- Position
- Salary
- David W. Nassif, J.D.
- Chief Executive Officer, Director, Chief Accounting Officer and General Counsel; Chief Financial Officer of the Company and ASI
- --
- Dr. Frank M. Torti, M.D.
- Chairman of the Board
- --
- Dr. Eric Venker
- Director
- --
- Dr. Atul Pande, M.D.
- Lead Independent Director
- --
- Berndt Modig
- Independent Director
- --
- Senthil Sundaram
- Independent Director
- --
- Dr. Kristiina Vuori, M.D.,PhD
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg